Gene: SNX3
Official Full Name: sorting nexin 3provided by HGNC
Gene Summary: This gene encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. This protein does not contain a coiled coil region, like most family members. This protein interacts with phosphatidylinositol-3-phosphate, and is involved in protein trafficking. A pseudogene of this gene is present on the sex chromosomes. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02482 | SNX3 Knockout cell line (HeLa) | Human | SNX3 | 1:3~1:6 | Negative | Online Inquiry |
KO02483 | SNX3 Knockout cell line (HCT 116) | Human | SNX3 | 1:2~1:4 | Negative | Online Inquiry |
KO02484 | SNX3 Knockout cell line (HEK293) | Human | SNX3 | 1:3~1:6 | Negative | Online Inquiry |
KO02485 | SNX3 Knockout cell line (A549) | Human | SNX3 | 1:3~1:4 | Negative | Online Inquiry |
SNX3 Gene Knockout Cell Lines are specially developed cellular models designed to facilitate the in-depth study of the functions and pathways associated with the sorting nexin 3 (SNX3) gene. These cell lines are generated using advanced genome editing technologies, specifically CRISPR-Cas9, to precisely knock out the SNX3 gene. This loss-of-function approach enables researchers to decipher the biological roles of SNX3 in cellular processes, including protein trafficking, endosomal sorting, and receptor recycling.
The primary mechanism of action of SNX3 involves its role in the endocytic pathway, where it is implicated in modulating cellular responses to extracellular signals by regulating cargo sorting at endosomes. By utilizing SNX3 Gene Knockout Cell Lines, scientists can investigate how the absence of this gene influences cellular outcomes, paving the way for discoveries in areas such as cell signaling, metabolism, and pathogenesis of diseases.
The scientific importance of these cell lines extends to various applications in academic research, drug discovery, and therapeutic development. They serve as a vital tool for exploring the implications of SNX3 in diseases, potentially revealing novel therapeutic targets. In clinical settings, insights gained from these models can contribute to understanding disorders related to endosomal dysfunction, such as neurodegenerative diseases and cancers.
What sets SNX3 Gene Knockout Cell Lines apart from traditional models is their specificity and the precision of the genetic manipulation, resulting in minimal off-target effects. This specificity allows for clearer interpretations of results, which is crucial for rigorous scientific investigations.
Researchers, clinicians, and pharmaceutical companies will find considerable value in these cell lines as they provide robust, reproducible data essential in advancing our understanding of cellular mechanisms and disease pathology. By incorporating SNX3 Gene Knockout Cell Lines into their studies, users can enhance the reliability of their research and contribute meaningfully to the broader scientific community.
Our company prides itself on expertise in developing high-quality, precision-engineered biological products that empower researchers to push the boundaries of scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.